C

CEL-SCI Corporation NYSE; CVM

40 employees

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

1983

Funding rounds raised

Total raised

$5.5M

from 2 investors over 2 rounds

C

CEL-SCI Corporation NYSE; CVM raised $5.5M on December 28, 2019

Investors: Aegis Capital

C

CEL-SCI Corporation NYSE; CVM raised $4.4M on August 20, 2009

Investors: MidOcean Partners

FAQ